Vitaly Terushkin

Vitaly Terushkin practices at David S. Becker, M.D. in New York, New York.

Vitaly Terushkin's NPI, 1699099671, was assigned on March 20, 2010. Vitaly Terushkin graduated from New York University School of Medicine in 2010. Vitaly Terushkin holds New York license 269373.

Vitaly Terushkin's primary practice is David S. Becker, M.D., at 205 E 69th St, New York, NY 10021 in New York County. The practice phone is (212) 772-3600.

Vitaly Terushkin's primary practice is David S. Becker, M.D. in New York, New York. The medical group on file is The Medical Group of New Jersey, Navesink Dermatology. Dmand AI also links Vitaly Terushkin to 3 more medical groups, 2 group practices and clinics and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vitaly Terushkin practices, 3 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Vitaly Terushkin's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dmand AI has Vitaly Terushkin's licenses on file in 3 states: New York, New Jersey and Pennsylvania.

CMS data shows 4,971 Medicare services from Vitaly Terushkin across 32 procedure codes in 2024, for 1,420 Medicare patients. Medicare paid $1,402,881 for them. Every service was in an office.

CMS counts 1,420 Medicare patients who saw Vitaly Terushkin in 2024. The largest group is 75 to 84, with 655 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Vitaly Terushkin's median patient age at 70, with 41% women.

In 2024, Vitaly Terushkin wrote 381 Medicare Part D claims for 175 patients. 100% of them were for generic drugs. CMS names the drug for 342 of them, across 3 drugs with 11 or more claims each, at $4,805 in total drug cost. In 2023, CMS named 378 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Vitaly Terushkin for performance year 2024, reported as part of a group. Vitaly Terushkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 255 procedures of melanoma (skin cancer) excision by Vitaly Terushkin, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 38 general payments to Vitaly Terushkin from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merz North America, Inc. paid the most, $154.

Vitaly Terushkin graduated from New York University School of Medicine in 2010.